Phase I study of Ibrutinib with radiation and temozolomide in patients with newly diagnosed grade III gliomas and Glioblastoma

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/171/1/22

Funding

  • Pharmacyclics: $636,217.00